France· FR:61054849
CAYSTON 75 mg, poudre et solvant pour solution pour inhalation par nébiliseur
A medicinal product containing aztréonam de lysine, registered in France by GILEAD SCIENCES IRELAND UC (IRLANDE), on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- AZTRÉONAM DE LYSINE
- Manufacturer
- GILEAD SCIENCES IRELAND UC (IRLANDE)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip13340093751511584 flacon(s) en verre - 88 ampoule(s) polyéthylène basse densité (PEBD) avec nébulisateur AlteraEUR 2.1
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Aztréonam de lysine in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CanadaCAYSTONGILEAD SCIENCES CANADA INC
- FinlandCaystonGilead Sciences Ireland UC
- NetherlandsCayston 75 mg, poeder voor verneveloplossingGilead Sciences Ireland UC
- SwedenCayston 75 mg Pulver till lösning för nebulisatorGilead Sciences Ireland UC
- United StatesAZACTAME.R. Squibb & Sons, L.L.C.
- United KingdomAzactam 1g powder for solution for injection vialsKent Pharma (UK) Ltd
- IrelandAzactam 1 g Powder for Solution for Injection or InfusionAthlone Pharmaceuticals Limited
- BelgiumAzactam 1 gLaboratoires Delbert
Authorised across Europe · EMA
The same active substance is authorised in 13 EEA countries. Names it is sold under:
- Austria · Azactam
- Belgium · Azactam
- Spain · Azactam
- Finland · Azactam
- United Kingdom (Northern Ireland) · Aztreonam Kent Pharma Uk, Aztreonam Kent Pharma Uk Ltd
- Ireland · Azactam
- Iceland · Cayston
- Liechtenstein · Cayston
- Luxembourg · Azactam
- Norway · Azactam, Cayston
- Portugal · Azactam
- Romania · Azactam
- Sweden · Azactam
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fe536f70-3483-4acc-8627-2069908ed7c0 GET /v1/drugs/fe536f70-3483-4acc-8627-2069908ed7c0?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "61054849",
"date_amm": "2009-09-21",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/09/543",
"substance": "AZTRÉONAM DE LYSINE",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "poudre et solvant pour solution pour inhalation par nébuliseur",
"voies_administration": "inhalée",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about aztréonam de lysine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.